MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-04-0006599
Dr. Brita Pharmaceutical Private Limited (OPC)
Dr. Brita Pharmaceutical Private Limited (OPC) - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹3.48 Cr
▲ 533% YoY
Net profit · FY 2025
₹1.03 Lakh
Net margin 0.3%
EBITDA · FY 2025
₹15.51 Lakh
EBITDA margin 4.5%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹41 Lakh
Issued & subscribed
Open charges
₹3 Cr
Satisfied ₹3 Cr
Company age
10 yrs
Est. 2016
Directors on board
1
As per MCA filings
About Dr. Brita Pharmaceutical Private Limited (OPC)
Data last updated:
Dr. Brita Pharmaceutical Private Limited (OPC) is a one person company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 09 July 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33100DL2016OPC302743. The company has 2 GST registrations on record, none of which is active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹41 Lakh. It is led by director Jasraj Singh.
Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 6 Shop No. 3, Csc Paschim Vihar, New Delhi, Delhi, India – 110063.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.48 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹1.03 Lakh (net margin 0.3%) and EBITDA of ₹15.51 Lakh (EBITDA margin 4.5%). Revenue has grown at a compounded annual rate (CAGR) of 108% over three years.
As per MCA filings, the company has open charges of ₹3 Cr and satisfied charges of ₹3 Cr on record.
Dr. Brita Pharmaceutical Private Limited (OPC) is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-04-0006599). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U33100DL2016OPC302743
Registration Number 302743
Incorporation Date 09 July 2016
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 31 December 2020
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-04-0006599
Key People
Jasraj Singh Director Recognitions & Rankings of Dr. Brita Pharmaceutical Private Limited (OPC)
Contact details
Dr. Brita Pharmaceutical Private Limited (OPC)'s registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressA – 6 Shop No. 3, Csc Paschim Vihar, New Delhi, Delhi, India – 110063
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Dr. Brita Pharmaceutical Private Limited (OPC), buy the company report.
Comprehensive company report
Dr. Brita Pharmaceutical Private Limited (OPC) - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Dr. Brita Pharmaceutical Private Limited (OPC) is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Dr. Brita Pharmaceutical Private Limited (OPC), buy the company report.
Financials of Dr. Brita Pharmaceutical Private Limited (OPC)
FY 2025 filings availableDr. Brita Pharmaceutical Private Limited (OPC) reported revenue of ₹3.48 Cr (up 533% YoY) for FY 2025.
Revenue · FY 2025
₹3.48 Cr ▲ 533%
Net profit · FY 2025
₹1.03 Lakh margin 0.3%
EBITDA · FY 2025
₹15.51 Lakh margin 4.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 533%
3 years · compounded
▲ 108%
EBITDA CAGR growth
1 year
▲ 440%
3 years · compounded
▲ 830%
5 years · compounded
▲ 153%
Revenue has grown at a compounded annual rate (CAGR) of 108% over three years, including 533% growth in the latest year. EBITDA rose 440% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹15.51 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.03 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.5% | ||||
| Net Profit Margin | 0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Dr. Brita Pharmaceutical Private Limited (OPC), buy the company report.
Board of directors of Dr. Brita Pharmaceutical Private Limited (OPC)
Dr. Brita Pharmaceutical Private Limited (OPC) has 1 current director and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jasraj Singh | Director | 16 Mar 2023 | 3 Years 7 Months | Current |
Peer comparison
Dr. Brita Pharmaceutical Private Limited (OPC) is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Genip Pharmaceuticals Private Limited | ₹3.5 Cr (FY 2025) | 12.0% | Hyderabad, Telangana, India | |||
| Zeneris Pharma Private Limited | ₹3.5 Cr (FY 2025) | 74.0% | New Delhi, Delhi, India | |||
| Mediwave Life Sciences Private Limited | ₹3.5 Cr (FY 2025) | 11.0% | Hyderabad, Telangana, India | |||
| Dr. Brita Pharmaceutical Private Limited (OPC)this company | ₹3.48 Cr (FY 2025) | ₹1.03 Lakh | 0.3% | 533.0% | New Delhi, Delhi, India | |
| Winsmed Pharmaceuticals Private Limited | ₹3.48 Cr (FY 2023) | 57.0% | Gorakhpur, Uttar Pradesh, India | |||
| R.J. Distributors Private Limited | ₹3.47 Cr (FY 2025) | 19.0% | Thane, Maharashtra, India | |||
| Teja Pharma Private Limited | ₹3.46 Cr (FY 2018) | -46.0% | Thiruvallur, Tamil Nadu, India |
To see the full peer comparison of Dr. Brita Pharmaceutical Private Limited (OPC), buy the company report.
Auditor
Dr. Brita Pharmaceutical Private Limited (OPC) is audited by SAAWARIYA & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SAAWARIYA & CO. | FY 2017 | 022252N |
Shareholding
The shareholding of Dr. Brita Pharmaceutical Private Limited (OPC) is on record for FY 2017, split between promoters, domestic institutions and public shareholders.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public |
To see the full shareholding pattern of Dr. Brita Pharmaceutical Private Limited (OPC), buy the company report.
Charges & borrowings
Open charges
₹3 Cr
Satisfied charges
₹3 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Oct 2024 | 100995902 | Indian Overseas Bank | ₹3 Cr | Satisfied |
To see the full charge records of Dr. Brita Pharmaceutical Private Limited (OPC), buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Dr. Brita Pharmaceutical Private Limited (OPC) are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dr. Brita Pharmaceutical Private Limited (OPC); the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Dr. Brita Pharmaceutical Private Limited (OPC) has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
Total GSTINs
2
Cancelled / inactive
2
To see the full GST registrations and return filing status of Dr. Brita Pharmaceutical Private Limited (OPC), buy the company report.
Recent activity
Dr. Brita Pharmaceutical Private Limited (OPC) has 4 board changes on record since 2016: 2 appointments and 2 cessations. The latest: Krishna Singh ceased to be Director on 17 Mar 2023.
Charges
A charge registered on 18 Oct 2024 via Charge ID 100995902 with Indian Overseas Bank was fully satisfied on 27 Jun 2025.
Filing
Dr. Brita Pharmaceutical Private Limited (Opc) has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Charges
A charge with Indian Overseas Bank amounted to Rs. 300.00 Lakh with Charge ID 100995902 was registered on 18 Oct 2024.
Ceased
Krishna Singh ceased to be Director.
Appointed
Jasraj Singh was appointed as Director.
Ceased
Jasbir Singh ceased to be Director.
AGM
Dr. Brita Pharmaceutical Private Limited (Opc) last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records.
Appointed
Krishna Singh was appointed as Nominee.
Incorporation
09 Jul 2016
Dr. Brita Pharmaceutical Private Limited (Opc) was registered on 09 Jul 2016 with Roc Delhi Ii & aged 10 years 3 months as per MCA records.
Frequently asked questions
Dr. Brita Pharmaceutical Private Limited (OPC) is an active company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 09 July 2016 (10+ years old) and is registered under CIN U33100DL2016OPC302743.
Dr. Brita Pharmaceutical Private Limited (OPC) has 1 current director:
- Jasraj Singh - Director
The latest financial statements of Dr. Brita Pharmaceutical Private Limited (OPC) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 December 2020. Year-wise statements from FY 2017 are in the company report.
No. Dr. Brita Pharmaceutical Private Limited (OPC) has 2 GST registrations on record and all of them are cancelled or inactive.
The CIN (Corporate Identification Number) of Dr. Brita Pharmaceutical Private Limited (OPC) is U33100DL2016OPC302743. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dr. Brita Pharmaceutical Private Limited (OPC) was incorporated on 09 July 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Dr. Brita Pharmaceutical Private Limited (OPC) by revenue are Genip Pharmaceuticals Private Limited, Zeneris Pharma Private Limited, Mediwave Life Sciences Private Limited, Winsmed Pharmaceuticals Private Limited, R.J. Distributors Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Krishna Singh ceased to be Director on 17 Mar 2023. Jasraj Singh was appointed as Director on 16 Mar 2023. Jasbir Singh ceased to be Director on 03 Apr 2021. Dr. Brita Pharmaceutical Private Limited (OPC) has 4 board changes on record in total.
Yes, Dr. Brita Pharmaceutical Private Limited (OPC) is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-04-0006599).
The registered office of Dr. Brita Pharmaceutical Private Limited (OPC) is at A – 6 Shop No. 3, Csc Paschim Vihar, New Delhi, Delhi, India – 110063.
Dr. Brita Pharmaceutical Private Limited (OPC) operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages